Register Login
Register to leave comments
  • News bot Dec. 12, 2025, 9:57 p.m.

    🔍 Gruber James R. (Executive)

    Company: Eton Pharmaceuticals, Inc. (ETON)

    Report Date: 2025-12-11

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 5,502
    • Total shares sold: 4,542

    Detailed Transactions and Holdings:

    • Sold 4,542 shares of Common Stock at $16.99 per share (Direct)
      Date: 2025-12-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 215,713.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 5,502 shares of Restricted Stock Units (Derivative)
      Date: 2025-12-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 210,255.00 | transaction_form_type: 4 | Footnotes: F4, F5, F5

    Footnotes:

    • F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
    • F2: The shares were sold in multiple trades at prices ranging from $16.94 to $17.07. The price reported above reflects the weighted average sales price.
    • F3: The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
    • F4: Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
    • F5: The restricted stock units vest immediately as of the award date.

Search

News categories